Oncotarget

Research Papers:

Coregulator profiling of the glucocorticoid receptor in lymphoid malignancies

Dorien Clarisse, Jonathan Thommis, Karlien Van Wesemael, René Houtman, Dariusz Ratman, Jan Tavernier, Fritz Offner, Ilse Beck and Karolien De Bosscher _

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2017; 8:109675-109691. https://doi.org/10.18632/oncotarget.22764

Metrics: PDF 1241 views  |   HTML 2623 views  |   ?  


Abstract

Dorien Clarisse1,2,3, Jonathan Thommis1, Karlien Van Wesemael2,4, René Houtman5, Dariusz Ratman1,6, Jan Tavernier1,3, Fritz Offner4, Ilse Beck2,7,* and Karolien De Bosscher1,3,*

1Receptor Research Laboratories, Nuclear Receptor Lab (NRL) and Cytokine Receptor Lab (CRL), VIB-UGent Center for Medical Biotechnology, Ghent University, Ghent, Belgium

2Laboratory of Experimental Cancer Research (LECR), Department of Radiation Oncology and Experimental Cancer Research, Ghent University, Ghent, Belgium

3Cancer Research Institute Ghent (CRIG), Ghent, Belgium

4Hematology, Department of Internal Medicine, Ghent University Hospital, Ghent, Belgium

5PamGene International B.V., ‘s Hertogenbosch, The Netherlands

6Current/Present address: Roche Global IT Solutions, Roche-Polska, Warsaw, Poland

7Department of Health Sciences, Odisee University College, Ghent, Belgium

*These authors have contributed equally to this work

Correspondence to:

Karolien De Bosscher, email: [email protected]

Keywords: coregulator; glucocorticoid; glucocorticoid receptor; multiple myeloma; acute lymphoblastic leukemia

Received: September 16, 2017    Accepted: November 14, 2017    Published: November 30, 2017

ABSTRACT

Coregulators cooperate with nuclear receptors, such as the glucocorticoid receptor (GR), to enhance or repress transcription. These regulatory proteins are implicated in cancer, yet, their role in lymphoid malignancies, including multiple myeloma (MM) and acute lymphoblastic leukemia (ALL), is largely unknown. Here, we report the use and extension of the microarray assay for real-time nuclear receptor coregulator interactions (MARCoNI) technology to detect coregulator associations with endogenous GR in cell lysates. We use MARCoNI to determine the GR coregulator profile of glucocorticoid-sensitive (MM and ALL) and glucocorticoid-resistant (ALL) cells, and identify common and unique coregulators for different cell line comparisons. Overall, we identify SRC-1/2/3, PGC-1α, RIP140 and DAX-1 as the strongest interacting coregulators of GR in MM and ALL cells and show that the interaction strength does not correlate with GR protein levels. Lastly, as a step towards patient samples, we determine the GR coregulator profile of peripheral blood mononuclear cells. We profile the interactions between GR and coregulators in MM and ALL cells and suggest to further explore the GR coregulator profile in hematological patient samples.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 22764